Patient Information Leaflet: User Information
Abrea, 75 mg, enteric-coated tablets
Abrea, 100 mg, enteric-coated tablets
Abrea, 160 mg, enteric-coated tablets
Acetylsalicylic acid
Read the leaflet carefully before taking the medicine, as it contains important information for the patient.
This medicine should always be taken exactly as described in this patient information leaflet or as directed by your doctor, pharmacist, or nurse.
- Keep this leaflet, you may need to read it again.
- If you need advice or further information, consult your pharmacist.
- If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. See section 4.
- If you do not feel better or if you feel worse, consult your doctor.
Table of Contents of the Leaflet
- 1. What is Abrea and what is it used for
- 2. Important information before taking Abrea
- 3. How to take Abrea
- 4. Possible side effects
- 5. How to store Abrea
- 6. Contents of the pack and other information
1. What is Abrea and what is it used for
Abrea contains acetylsalicylic acid, which in low doses belongs to a group of medicines called antiplatelet agents. Platelets are small blood cells that cause blood clots to form and are involved in thrombosis. When a blood clot forms in an artery, it can block the flow of blood and cut off oxygen supply. If this happens in the heart, it can cause a heart attack or angina; and in the brain, it can cause a stroke.
- heart attacks
- strokes
- cardiovascular diseases in patients with stable or unstable angina (a type of chest pain).
Abrea is also used to prevent blood clots after heart surgery to widen or unblock blood vessels.
2. Important information before taking Abrea
When not to take Abrea
- if you are allergic to acetylsalicylic acid or any of the other ingredients (listed in section 6);
- if you are allergic to other salicylates or non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are often used to treat arthritis, rheumatism, and pain;
- if you have ever had an asthma attack or swelling of certain parts of the body, such as the face, lips, tongue, or throat (angioedema), after taking salicylates or NSAIDs;
- if you currently have or have had stomach or duodenal ulcers, or any other type of bleeding, such as a stroke;
- if you have ever had bleeding disorders;
- in case of severe liver or kidney problems;
- if you have severe heart problems that cause shortness of breath and swelling of the ankles;
- during the third trimester of pregnancy; do not take more than 100 mg per day (see also section "Pregnancy and breastfeeding");
- if you are taking methotrexate (e.g., for cancer or rheumatoid arthritis) at a dose greater than 15 mg per week.
Warnings and precautions
Before taking Abrea, consult your doctor or pharmacist:
- if you have kidney, liver, or heart problems;
- if you have or have had stomach or small intestine problems;
- in case of uncontrolled high blood pressure;
- if you have asthma, hay fever, nasal polyps, or other chronic respiratory diseases; acetylsalicylic acid may cause an asthma attack;
- if you have ever had gout;
- in case of heavy menstrual bleeding;
- if you have a deficiency of the enzyme glucose-6-phosphate dehydrogenase (G6PD).
You should immediately consult your doctor if your symptoms worsen or if you experience severe or unexpected side effects, such as unusual bleeding, severe skin reactions, or any other symptoms of severe hypersensitivity (see section "Possible side effects").
Children and adolescents
Acetylsalicylic acid should not be given to children and adolescents under 16 years of age, unless advised by a doctor (see section "Warnings and precautions").
Abrea and other medicines
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take.
- antiplatelet agents - preventing blood clots or dissolving clots (e.g., warfarin, heparin, clopidogrel, alteplase);
- medicines to prevent transplant rejection after a transplant operation (cyclosporine, tacrolimus);
- antihypertensive medicines (e.g., diuretics and ACE inhibitors);
- medicines to regulate heart rhythm (digoxin);
- medicines used to treat manic-depressive states (lithium);
- analgesic and anti-inflammatory medicines (e.g., NSAIDs like ibuprofen or steroids);
- analgesic and antipyretic medicines (metamizol), the effect of acetylsalicylic acid on platelet aggregation may be reduced after concomitant administration with metamizol.
- medicines used to treat gout (e.g., probenecid);
- medicines used to treat epilepsy (valproate, phenytoin);
- medicines used to treat glaucoma (acetazolamide);
- medicines used to treat cancer or rheumatoid arthritis (methotrexate at a dose less than 15 mg per week);
- medicines used to treat diabetes (e.g., glibenclamide, insulin);
- medicines used to treat depression (selective serotonin reuptake inhibitors like sertraline or paroxetine);
- medicines used in hormone replacement therapy in patients with adrenal or pituitary gland problems or in the treatment of inflammation, including rheumatoid diseases and colitis (corticosteroids).
Abrea with food, drink, and alcohol
Drinking alcohol may increase the risk of gastrointestinal bleeding and prolong bleeding time.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
Driving and using machines
Abrea does not affect the ability to drive or use machines.
Abrea contains lactose
If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Abrea 75 mg contains sunset yellow FCF (E 110)
which may cause allergic reactions.
Abrea 160 mg contains lecithin
Do not use if you are allergic to peanuts or soy.
3. How to take Abrea
Always take this medicine exactly as described in this patient information leaflet or as directed by your doctor or pharmacist.
- Recommended dose is 75-160 mg once daily.
Prevention of stroke:
- Recommended dose is 75-325 mg once daily.
Prevention of cardiovascular disorders in patients with stable or unstable angina:
- Recommended dose is 75-160 mg once daily.
Prevention of blood clots after certain heart surgeries:
- Recommended dose is 75-160 mg once daily.
Do not take more than the recommended dose unless advised by your doctor.
Children and adolescents
Do not give acetylsalicylic acid to children and adolescents under 16 years of age unless advised by a doctor (see section "Warnings and precautions").
Method of administration
Oral use.
Swallow the tablets whole with a sufficient amount of liquid (1/2 glass of water) at least 30 minutes before meals. The tablets have a coating that protects the stomach and intestines from irritation, so do not crush, break, or chew them.
Overdose
If you (or someone else) have taken too many tablets, contact your doctor or go to the nearest hospital emergency department immediately. Show the doctor the package or remaining tablets.
Missed dose
If you miss a dose, wait until the next scheduled dose and continue as usual. Do not take a double dose to make up for the missed dose.
Stopping Abrea
Do not stop taking Abrea without consulting your doctor.
4. Possible side effects
Like all medicines, Abrea can cause side effects, although not everybody gets them.
If you experience any of the following serious side effects, stop taking Abrea and contact your doctor immediately:
- Sudden onset of wheezing, swelling of the face, lips, tongue, or throat, rash, fainting, or difficulty swallowing (severe allergic reactions).
- Redness of the skin with blisters or peeling of the skin, which may be associated with high fever and joint pain. This may be erythema multiforme, Stevens-Johnson syndrome, or Lyell's syndrome.
- Unexpected bleeding, such as coughing up blood, blood in vomit or urine, or black stools.
Other side effects:
Common side effects (may affect up to 1 in 10 people):
- Nausea, vomiting, diarrhea.
- Indigestion.
- Increased tendency to bleed.
Uncommon side effects (may affect up to 1 in 100 people):
- Hives.
- Hay fever.
- Breathing difficulties.
Rare side effects (may affect up to 1 in 1,000 people):
- Severe bleeding from the stomach or intestines, cerebral bleeding; altered blood cell count.
- Lower respiratory tract spasms, asthma attack.
- Vasculitis.
- Purpura with purple spots (bleeding into the skin).
- Severe skin reactions like erythema multiforme and its life-threatening forms, Stevens-Johnson syndrome, and Lyell's syndrome.
- Hypersensitivity reactions, such as swelling, e.g., of the lips, face, or body, or anaphylaxis.
- Reye's syndrome (a very rare disease that affects the brain and liver and can be life-threatening - see section 2 "Children and adolescents").
- Abnormal heavy or prolonged menstrual bleeding.
Side effects with unknown frequency (frequency cannot be estimated from available data):
- Ringing in the ears (tinnitus) or hearing loss.
- Headache.
- Dizziness.
- Stomach or small intestine ulcers or perforation.
- Prolonged bleeding time.
- Kidney problems, acute kidney failure.
- Liver problems, increased liver enzyme activity.
- High uric acid levels or low blood sugar levels.
Reporting side effects
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products.
5. How to store Abrea
Keep the medicine out of the sight and reach of children.
Do not store above 25°C.
Store in the original package to protect from light.
Do not use this medicine after the expiry date stated on the blister and carton after EXP.
The expiry date refers to the last day of the month.
The batch number is stated on the packaging after the abbreviation "Lot".
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
What Abrea contains
- The active substance is acetylsalicylic acid. Each enteric-coated tablet contains 75 mg, 100 mg, or 160 mg of acetylsalicylic acid.
- Other ingredients of Abrea 75 mg are tablet core: lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, potato starch. First coating: talc, triacetin, methacrylic acid, and ethyl acrylate copolymer (1:1), 30% dispersion, sodium dodecyl sulfate* and polysorbate 80*. Second coating: polyvinyl alcohol (E 1203), titanium dioxide (E 171), macrogol 3350, talc, carmine (E 120), sunset yellow FCF (E 110), aluminum lake.
- Other ingredients of Abrea 100 mg are tablet core: lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, potato starch. Coating: talc, triacetin, methacrylic acid, and ethyl acrylate copolymer (1:1), 30% dispersion, sodium dodecyl sulfate* and polysorbate 80*.
- Other ingredients of Abrea 160 mg are tablet core: lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, potato starch. First coating: talc, triacetin, methacrylic acid, and ethyl acrylate copolymer (1:1), 30% dispersion, sodium dodecyl sulfate* and polysorbate 80*. Second coating: polyvinyl alcohol, talc, titanium dioxide (E 171), macrogol 3350, lecithin, yellow iron oxide (E 172).
*May contain sodium dodecyl sulfate and polysorbate 80.
What Abrea looks like and contents of the pack
Abrea 75 mg - pink, round, biconvex, enteric-coated tablets with a diameter of about 7.2 mm.
Abrea 100 mg - white, round, biconvex, enteric-coated tablets with a diameter of about 8.1 mm.
Abrea 160 mg - yellow, round, biconvex, enteric-coated tablets with a diameter of about 9.2 mm.
Package sizes:
Blister: 20, 28, 30, 50, 56, 60, 84, 90, or 100 enteric-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
KRKA-POLSKA Sp. z o.o.
ul. Równoległa 5
02-235 Warszawa
Tel. 22 57 37 500
This medicine is authorized in the Member States of the European Economic Area under the following names:
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany |
G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria | |
Sweden | Bartal 75 mg Enterotablett Bartal 100 mg Enterotablett Bartal 160 mg Enterotablett |
Czech Republic | Acetylsalicylic acid Krka |
Germany | ASS TAD 75 mg protect magensaftresistente Tabletten ASS TAD 100 mg protect magensaftresistente Tabletten |
Slovakia | Abrea 75 mg Abrea 100 mg Abrea 160 mg |
Spain | Ácido acetilsalicílico Krka 100 mg comprimidos gastroresistents |
Date of last revision of the leaflet: 26.05.2023